- Telehealth Visits
- Insurance plan information
Michael Roberts, MD
Allergy and Immunology • Pediatrics- Telehealth Visits
- Insurance plan information
Michael Roberts, MD
Allergy and Immunology • Pediatrics- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- General Pediatrics, American Board of Pediatrics
- Allergy & Immunology, American Board of Allergy and Immunology
Fellowship
- Allergy/Immunology, Children's Hospital Los Angeles GME
Residency
- Pediatrics, University of Texas Health Science Ctr - Houston
Internship
- Transitional, Mary Imogene Bassett Hospital
Degree
- MD, University of Miami School of Medicine
My expertise
Specialties
- Allergy and Immunology
- Pediatrics
Clinical Trials query: q=health_gateway_id_ss%3A%28%221442%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221442%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 21 reviews
- October 23, 20255 out of 5 Stars
Once I got into my appointment, I never felt rushed, both Rosie and Dr. Roberts took their time and let me ask all the questions I needed to which I really appreciated.
- August 10, 20255 out of 5 Stars
Dr. Roberts is an excellent doctor, communication with me.
- July 27, 20255 out of 5 Stars
I've already recommended to a few friends!
- July 5, 20255 out of 5 Stars
Dr. Roberts was very personable and highly competent, I couldn't have asked for more.
- May 17, 20255 out of 5 Stars
Had a great experience with Dr. Roberts! Everyone in the office was really helpful.
- May 7, 20255 out of 5 Stars
Dr. Roberts was such a great resource and has helped me map out a plan with managing, confirming, and possibly treating some of my allergies.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.